Skip to content

QuantumScape Corporation QS Payments Of Stock Issuance Costs

Payments Of Stock Issuance Costs at other companies

STU
StubHub Holdings, Inc.STUB
$2.06M
Immunovant, Inc. logo
Immunovant, Inc.IMVT
$126K-60.5%
Hinge Health, Inc. logo
Hinge Health, Inc.HNGE
$0-100%
NNN REIT logo
NNN REITNNN
$100K+17.6%
CG Oncology logo
CG OncologyCGON
$47K-79.7%
QuantumScape Corporation
 logo
QuantumScape Corporation QS
$101K-85.7%

Other financials

Income statement

See full
Operating income-$109.2M+11.6%
Net income-$100.8M+11.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$145.1M-5.5%
Total debt$72.9M-23.1%
Total equity$1.1B+0.1%
Total assets$1.2B-2.4%

Cash flow

See full
Operating cash flow-$59.5M+2.0%
CapEx$10.0M+71.0%
Free cash flow-$69.5M-4.4%

Valuation

See full
Market cap$4.95B+71.8%
Enterprise value$4.87B+73.1%

Returns & leverage

See full
Return on equity-38%-1.7pp
Debt / equity0.1×0.0×
Current ratio20.9×+4.3×

Where this comes from

Reported directly by QuantumScape Corporation in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.

The official record: QuantumScape Corporation ’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuantumScape Corporation 's payments of stock issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuantumScape Corporation 's payments of stock issuance costs?
QuantumScape Corporation (QS) reported payments of stock issuance costs of $101K in Q4 2025.
How has QuantumScape Corporation 's payments of stock issuance costs changed year-over-year?
QuantumScape Corporation 's payments of stock issuance costs decreased by 85.7% year-over-year, from $704.25K to $101K.
What does payments of stock issuance costs mean?
This captures the direct costs incurred by the company to issue new equity, such as underwriting fees, legal expenses, and registration costs. These costs are deducted from the gross proceeds of equity offerings, representing a friction cost of raising capital. Tracking these expenses is important for evaluating the efficiency of the company's capital-raising activities.